NAROPIN

Product NDC
52584-286
11-digit product format
525840286
Labeler code
52584
Product ID
52584-286_964e7997-ac3a-42a8-98d8-4a9f96979153
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ropivacaine hydrochloride
Dosage form
INJECTION, SOLUTION
Route
EPIDURAL; INFILTRATION; PERINEURAL
Labeler
General Injectables & Vaccines, Inc
Application
NDA020533
Marketing category
NDA
Marketing start
2014-03-11
Marketing end
0000-00-00
Substance
ROPIVACAINE HYDROCHLORIDE
Active strength
5 mg/mL
Pharmacologic classes
Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
52584-286NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [GENERAL INJECTABLES & VACCINES, INC]9Legacy NDC20230125_096c2693-8488-48c2-88ee-bf3df95c3f4c.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
52584-286-35525840286351 VIAL, SINGLE-DOSE in 1 BAG (52584-286-35) > 30 mL in 1 VIAL, SINGLE-DOSE2014-03-110000-00-00NoNoCurrent